Results - Announcements
IOL Chemicals & Pharmaceuticals Ltd share price inched up 2.35% to Rs 184.85 after the company's net profit soared by 21.14% to Rs 64.4 crore, while revenue from operations gained significantly 22.09% to Rs 756.26 crore in Q2FY26 over Q1FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.58 lakh crore, easing 4.54%. It has marginally improved by 5.74% over last one week and gained upto 0.60% in last one month while the market capitalization of IOL Chemicals & Pharmaceuticals Ltd has gained 13.13% and 26.44% in the same period respectively.
Profit before tax (PBT) of IOL Chemicals & Pharmaceuticals Ltd stood at Rs 86.69 crore in Q2 FY26, jumping 90.49% year-on-year, and surging by 22.43% quarter-on-quarter. EBITDA came in at Rs 95 crore, expanding by 74.02% YoY and rising 5.16% sequentially.
Total expenses surged 23.18% to Rs 674.11 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 506.76 crore, soaring by 26.17% YoY, while employee benefits expense was at Rs 71.21 crore, inching up 1.25% YoY.
For the TTM ended FY26, revenue from operations grew 11.54% to Rs 2319.06 crore, while net profit jumped 36.18% to Rs 137.64 crore, compared to previous TTM. EBITDA jumped by 18713% to Rs 247.59 crore, and PBT soared 33.63% to Rs 184.36 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 214.32 crore in FY26, as against Rs 178.62 crore in FY25.
IOL Chemicals & Pharmaceuticals Ltd surged by 95.40% in last one year, significantly outperforming the benchmark BSE Sensex which has declined by 12.76% during the same period.